Machine Learning Pills
David AndrésWeekly pill-sized articles on key AI, Machine Learning and Data Science concepts.
| Platform |  | Pricing | Freemium | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 193 | Founded | 3 years ago | Last Issue | 5 days ago |
| Active | |||||
Read this Newsletter
mlpills.substack.comLatest Issues
DIY #23 - Predict Customer Lifetime Value
In the previous issue, we walked through the business lifecycle of an LTV prediction project: define the value metric, collect day-60 customer signals, avoid leakage, split by acquisition cohort, evaluate by ranking quality, and use the sco...
Weekly Dose #7 - Model Choice Is Now Infrastructure, Security, and Geopolitics
📰 The Weekly Dose
Welcome back to the Weekly Dose: your 5-minute breakdown of the AI/ML news that matters when you’re building, evaluating, deploying, or operating AI systems.
This edition covers 11 June to 19 June 2026. Last week’s is...
MLflow. Stop losing your best experiments: companion notebook
Hello! As promised, here is the companion notebook for last Sunday’s issue:
Hello! As promised, here is the companion notebook for last Sunday’s issue:
Issue #134 - MLflow: stop losing your best experiments
You trained a model last week that hit 96% AUC. You tweaked some things, retrained, and now you cannot get it back. You do not remember the hyperparameters. The notebook has been edited. The model file is somewhere in a folder called models...
Weekly Dose #6 - The Safety Router Is the Product Now, and Your AI Bill Just Became an Architecture Decision
📰 The Weekly Dose
Welcome back to the Weekly Dose: your 5-minute breakdown of the AI/ML news that changed how us builders should think this week.
This week: Anthropic made model safety routing impossible to ignore, the AI price war tur...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Machine Learning Pills.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
\ud83d\udcbc Senior AI Engineer / Data Scientist • \ud83d\udc0d Python enthusiast
Social
Frequently Asked Questions
How can I access the email archive for Machine Learning Pills?
You can find recent issues that have been published by Machine Learning Pills on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Machine Learning Pills have?
To see how many people subscribe to Machine Learning Pills, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Machine Learning Pills?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Machine Learning Pills as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Machine Learning Pills?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Machine Learning Pills using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Machine Learning Pills?
Scroll up to where it says Related Newsletters to see other publications like Machine Learning Pills. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Machine Learning Pills?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.